Key facts
- It has raised $25.4M; the latest was Later Stage VC ($16.4M) in Sep 2025.
- Notable investors include Bpifrance, Capital Grand Est, Groupe MACSF, Region Grand Est, Bernard Daugeras — 14 tracked in total.
- Status: Privately Held (backing).
- ·The complete investor list — 14 names
- ·Watchlist + deal alerts for RDS
- ·The full record, as it builds
Funding rounds
No funding rounds for RDS are on record yet — either the company hasn't raised institutional capital, or the raise hasn't surfaced in our sources.
About RDS
Developer of a remote patient monitoring platform designed to support continuous medical observation and telemonitoring. The company offers sensor-based data capture, patented monitoring technology, and integration with advanced clinical research initiatives, enabling healthcare providers and clinical teams to improve patient oversight and make more informed care decisions.
- Sector
- Healthcare
- HQ
- Strasbourg, France
- Founded
- 2020
- Employees
- 20
- Website
- rdsdiag.com/
- Ownership
- Privately Held (backing)
RDS doesn't have a composite mark yet — a PA Mark is published once enough pricing inputs exist (trade prints, fund marks, round prices). The rest of the record below builds toward it.
Recorded secondary trades
No secondary trades in RDS shares have been recorded yet. When a print lands — third-party, direct report, or platform — it appears here with structure, source, and price.
Institutional fund marks
No SEC-registered fund has reported a fair-value mark on RDS in its N-PORT filings yet. We sweep new filings monthly.